# Clinical Cases: Approach to Dyspnea

## Case 1: Acute Decompensated Heart Failure

### Patient Presentation
A 72-year-old woman with a history of heart failure with reduced ejection fraction (HFrEF, EF 30%), coronary artery disease status post CABG, type 2 diabetes mellitus, and chronic kidney disease stage 3 presents to the emergency department with worsening shortness of breath over the past 3 days. She reports orthopnea requiring 4 pillows to sleep (increased from her baseline of 2 pillows) and paroxysmal nocturnal dyspnea. She also noticed progressive bilateral lower extremity swelling and a 5-pound weight gain over the past week. She admits to dietary indiscretion at a family gathering and ran out of her furosemide last week.

### Vital Signs
- Blood Pressure: 165/95 mmHg
- Heart Rate: 98 bpm
- Respiratory Rate: 26/min
- Oxygen Saturation: 88% on room air
- Temperature: 36.8°C

### Physical Examination
- General: Sitting upright, moderate respiratory distress
- HEENT: JVP elevated to 14 cm H2O
- Cardiovascular: Tachycardic, irregular rhythm, S3 gallop present, 2/6 holosystolic murmur at apex
- Pulmonary: Bibasilar crackles extending to mid-lung fields
- Abdomen: Hepatomegaly, positive hepatojugular reflux
- Extremities: 3+ pitting edema to knees bilaterally

### Initial Workup
- **BNP**: 1,850 pg/mL (baseline 450 pg/mL)
- **Troponin I**: 0.06 ng/mL (mildly elevated)
- **Creatinine**: 1.8 mg/dL (baseline 1.4 mg/dL)
- **Sodium**: 132 mEq/L
- **Chest X-ray**: Cardiomegaly, bilateral pleural effusions, Kerley B lines, cephalization of pulmonary vessels

### Clinical Image
![Pulmonary Edema Chest X-ray](image_01.png)
*Figure 1: Chest radiograph demonstrating cardiomegaly, bilateral pleural effusions, pulmonary vascular congestion with cephalization, and Kerley B lines consistent with acute decompensated heart failure.*

**Image Source**: Educational illustration for teaching purposes.

### Questions

1. **What is the most likely diagnosis?**
   - A) Community-acquired pneumonia
   - B) Acute decompensated heart failure (ADHF)
   - C) Pulmonary embolism
   - D) COPD exacerbation

2. **What is the most appropriate initial management?**
   - A) Broad-spectrum antibiotics
   - B) IV loop diuretics and oxygen
   - C) Anticoagulation with heparin
   - D) Bronchodilators and steroids

3. **Which finding is most specific for elevated left-sided filling pressures?**
   - A) Peripheral edema
   - B) S3 gallop
   - C) Hepatomegaly
   - D) Elevated JVP

4. **How would you classify this patient's heart failure presentation?**

5. **What is the target for diuresis in this patient, and how would you monitor response?**

### Answers

1. **B) Acute decompensated heart failure (ADHF)** - The patient has classic signs and symptoms of ADHF including orthopnea, PND, weight gain, elevated JVP, S3 gallop, pulmonary crackles, peripheral edema, and elevated BNP with chest X-ray findings of pulmonary edema.

2. **B) IV loop diuretics and oxygen** - Initial management of ADHF includes IV loop diuretics (furosemide) to relieve congestion and supplemental oxygen to maintain SpO2 >90%. The typical starting dose is 1-2.5 times the patient's home oral dose given IV.

3. **B) S3 gallop** - While all findings can be present in heart failure, an S3 gallop is most specific for elevated left ventricular filling pressures and indicates a non-compliant, volume-overloaded left ventricle. It correlates with elevated PCWP.

4. **Heart failure classification:**
   - **NYHA Class IV**: Symptoms at rest
   - **ACC/AHA Stage C**: Structural heart disease with prior or current HF symptoms
   - **Hemodynamic profile**: "Wet and warm" - congested (wet) with adequate perfusion (warm) as evidenced by normal blood pressure and lack of cool extremities
   - **Precipitating factors**: Dietary indiscretion, medication non-adherence

5. **Diuresis targets and monitoring:**
   - **Target**: Net negative 1-2 liters per day (or 0.5-1 kg weight loss/day)
   - **Monitoring**:
     - Daily weights (most important)
     - Strict intake/output
     - Electrolytes (K+, Mg2+, Na+) every 12-24 hours
     - Creatinine monitoring (mild rise acceptable)
     - Symptom improvement (dyspnea, orthopnea)
     - Physical exam (JVP, edema, lung sounds)
   - **Endpoint**: Return to "dry weight" with resolution of congestion

---

## Case 2: Pulmonary Embolism

### Patient Presentation
A 45-year-old woman presents to the emergency department with sudden-onset shortness of breath and right-sided pleuritic chest pain that started 6 hours ago. She returned from a 12-hour international flight 3 days ago. She has a history of obesity and uses oral contraceptive pills. She denies cough, fever, or leg swelling.

### Vital Signs
- Blood Pressure: 105/70 mmHg
- Heart Rate: 118 bpm
- Respiratory Rate: 24/min
- Oxygen Saturation: 91% on room air
- Temperature: 37.4°C

### Physical Examination
- General: Anxious, mild respiratory distress
- Cardiovascular: Tachycardic, regular rhythm, prominent P2, no murmurs
- Pulmonary: Clear to auscultation bilaterally
- Extremities: No edema, no calf tenderness, negative Homans sign

### Initial Workup
- **D-dimer**: 3,200 ng/mL (normal <500 ng/mL)
- **Troponin I**: 0.15 ng/mL (mildly elevated)
- **BNP**: 380 pg/mL (elevated)
- **ABG**: pH 7.48, PaCO2 28 mmHg, PaO2 68 mmHg on room air
- **ECG**: Sinus tachycardia, S1Q3T3 pattern, right axis deviation

### Questions

1. **What is the most likely diagnosis?**
   - A) Acute coronary syndrome
   - B) Spontaneous pneumothorax
   - C) Pulmonary embolism
   - D) Anxiety attack

2. **What is the most appropriate next diagnostic test?**
   - A) Transthoracic echocardiography
   - B) CT pulmonary angiography
   - C) Ventilation-perfusion scan
   - D) Lower extremity Doppler ultrasound

3. **Calculate the Wells score for this patient. What does it indicate?**

4. **What is the significance of the elevated troponin and BNP?**

5. **What would be the initial anticoagulation approach?**

### Answers

1. **C) Pulmonary embolism** - The patient has multiple risk factors (long flight, OCP use, obesity), sudden-onset dyspnea with pleuritic chest pain, tachycardia, hypoxemia, elevated D-dimer, and classic ECG findings (S1Q3T3).

2. **B) CT pulmonary angiography** - CTPA is the gold standard diagnostic test for PE with sensitivity and specificity >95%. It can also assess clot burden and right heart strain.

3. **Wells Score Calculation:**
   - Clinical signs of DVT: 0 points (none present)
   - PE most likely diagnosis: 3 points
   - Heart rate >100: 1.5 points
   - Immobilization >3 days or surgery in past 4 weeks: 0 points
   - Previous PE/DVT: 0 points
   - Hemoptysis: 0 points
   - Malignancy: 0 points
   - **Total: 4.5 points** - Moderate probability (2-6 points)

   With elevated D-dimer and moderate-high pretest probability, imaging is warranted.

4. **Significance of elevated cardiac biomarkers:**
   - **Troponin elevation**: Indicates right ventricular strain and myocardial injury due to acute pressure overload. Associated with worse prognosis.
   - **BNP elevation**: Reflects right ventricular dysfunction and wall stress. Combined with troponin elevation, suggests intermediate-high risk PE.
   - **Risk stratification**: This patient has submassive (intermediate-risk) PE based on biomarker elevation without hemodynamic instability.

5. **Initial anticoagulation approach:**
   - **Immediate**: Therapeutic anticoagulation with:
     - LMWH (enoxaparin 1 mg/kg BID) OR
     - Unfractionated heparin (if high bleeding risk or need for potential intervention) OR
     - DOAC (rivaroxaban or apixaban) can be started immediately
   - **Duration**: Minimum 3 months, longer if unprovoked or persistent risk factors
   - **Consideration for escalation**: If hemodynamic deterioration, consider systemic thrombolysis or catheter-directed therapy

---

## Learning Points

1. **BNP interpretation** helps differentiate cardiac from pulmonary causes of dyspnea - values >400-500 pg/mL strongly suggest cardiac etiology.

2. **ADHF management** focuses on decongestion with IV diuretics, targeting 1-2 L negative fluid balance daily.

3. **The Wells score** helps stratify pretest probability for pulmonary embolism and guides diagnostic testing.

4. **Right heart strain markers** (troponin, BNP, echo findings) in PE indicate intermediate-high risk and may influence management decisions.

5. **Systematic approach to dyspnea** should include assessment of onset, associated symptoms, vital signs, physical examination, and targeted investigations.
